InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
4
T+90 hit rate
82%
T+90 mean return
+8.3%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Miller Steve, Chief Operating Officer. Director active across 1 company, notably Catalyst Pharmaceuticals, INC.. Cumulatively, 23 disclosures have been published. Breakdown: 1 buy · 4 sells. Total volume traded: €3m. Activity tracked since 13 August 2021. The latest transaction was disclosed on 13 December 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations23 total
14,000 sharesCommon stock, par value $0.001 per shareSEC:0001161697-25-000494:0
13,667 sharesCommon stock, par value $0.001 per shareSEC:0001161697-25-000070:0
14,000 sharesCommon stock, par value $0.001 per shareSEC:0001161697-24-000542:0
235,000 shares@ US$4.0116.5% of flowCommon stock, par value $0.001 per shareSEC:0001161697-24-000523:0
11,872 sharesCommon stock, par value $0.001 per shareSEC:0001161697-24-000505:0
50,000 shares@ US$20.26116.7% of flowCommon stock, par value $0.001 per shareSEC:0001161697-24-000367:0
13,667 sharesCommon stock, par value $0.001 per shareSEC:0001161697-24-000103:0
14,000 sharesCommon stock, par value $0.001 per shareSEC:0001161697-23-000650:0
150,000 shares@ US$1.132.9% of flowCommon stock, par value $0.001 per shareSEC:0001161697-23-000621:0
40,000 shares@ US$14.249.6% of flowCommon stock, par value $0.001 per shareSEC:0001161697-23-000586:0
100,000 shares@ US$0.791.3% of flowCommon stock, par value $0.001 per shareSEC:0001161697-23-000286:0
13,666 sharesCommon stock, par value $0.001 per shareSEC:0001161697-23-000132:0
20,000 sharesCommon stock, par value $0.001 per shareSEC:0001161697-22-000576:0
80,000 shares@ US$15.27621.7% of flowCommon stock, par value $0.001 per shareSEC:0001161697-22-000561:0
25,000 shares@ US$17.0077.8% of flowCommon stock, par value $0.001 per shareSEC:0001161697-22-000456:0
118,575 shares@ US$2.535.5% of flowCommon stock, par value $0.001 per shareSEC:0001161697-22-000400:0
20,000 sharesCommon stock, par value $0.001 per shareSEC:0001161697-21-000559:0
20,000 sharesCommon stock, par value $0.001 per shareSEC:0001161697-21-000559
120,000 shares@ US$3.125.8% of flowCommon stock, par value $0.001 per shareSEC:0001161697-21-000410
120,000 shares@ US$3.120.0083% mcap32.4% of flowCommon stock, par value $0.001 per shareSEC:0001161697-21-000410:0
65,000 shares@ US$3.120.0045% mcap17.6% of flowCommon stock, par value $0.001 per shareSEC:0001161697-21-000385:0
65,000 shares@ US$3.123.2% of flowCommon stock, par value $0.001 per shareSEC:0001161697-21-000385
7,933 sharesCommon stock, par value $0.001 per shareSEC:0001161697-16-000618:0
Ideal exit: 7 Oct 2016 (T+270)
23 of 23 declarations
About Miller Steve
Steve Miller is the Chief Operating Officer at Catalyst Pharmaceuticals, Inc., a biopharmaceutical company. In this role, he is responsible for managing the company's operations, ensuring efficiency and process optimization. With experience in the biopharmaceutical sector, he plays a key role in improving operations and driving the company's growth.
